1. Home
  2. BXSL vs STVN Comparison

BXSL vs STVN Comparison

Compare BXSL & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Secured Lending Fund of Beneficial Interest

BXSL

Blackstone Secured Lending Fund of Beneficial Interest

HOLD

Current Price

$23.59

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.06

Market Cap

5.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXSL
STVN
Founded
2018
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Containers/Packaging
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.2B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BXSL
STVN
Price
$23.59
$19.06
Analyst Decision
Hold
Buy
Analyst Count
12
14
Target Price
★ $24.66
$24.47
AVG Volume (30 Days)
★ 1.4M
281.8K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
★ 13.18%
0.33%
EPS Growth
N/A
★ N/A
EPS
★ 0.15
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.96
Revenue Next Year
N/A
$9.15
P/E Ratio
$156.10
★ $27.15
Revenue Growth
N/A
N/A
52 Week Low
$22.47
$12.89
52 Week High
$28.59
$27.99

Technical Indicators

Market Signals
Indicator
BXSL
STVN
Relative Strength Index (RSI) 44.69 37.85
Support Level $23.25 $18.87
Resistance Level $25.00 $20.02
Average True Range (ATR) 0.40 0.59
MACD -0.02 -0.04
Stochastic Oscillator 39.76 26.25

Price Performance

Historical Comparison
BXSL
STVN

About BXSL Blackstone Secured Lending Fund of Beneficial Interest

Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies.

About STVN Stevanato Group S.p.A.

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

Share on Social Networks: